Cardiogenic shock

Cardiol Clin. 2013 Nov;31(4):567-80, viii. doi: 10.1016/j.ccl.2013.07.009. Epub 2013 Sep 20.

Abstract

Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often results in death. This life-threatening emergency requires intensive monitoring accompanied by aggressive hemodynamic support; other therapies are tailored to the specific pathophysiology. The development of novel therapeutic strategies is urgently required to reduce the unacceptably high mortality rates currently associated with CS.

Keywords: Acute myocardial infarction; Cardiogenic shock; Extracorporeal membrane oxygenation; Inflammation; Intra-aortic balloon pump; Left ventricular assist device; Prognosis; Reperfusion.

Publication types

  • Review

MeSH terms

  • Assisted Circulation / methods
  • Cardiovascular Agents / therapeutic use
  • Coronary Care Units
  • Extracorporeal Membrane Oxygenation
  • Heart Rupture, Post-Infarction / diagnosis
  • Heart Rupture, Post-Infarction / surgery
  • Heart-Assist Devices
  • Hemodynamics / physiology
  • Humans
  • Myocardial Revascularization / methods
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Shock, Cardiogenic / diagnosis
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / therapy*
  • Ventricular Dysfunction, Right / diagnosis
  • Ventricular Dysfunction, Right / therapy

Substances

  • Cardiovascular Agents